The Evolving Landscape of Treatments for Multiple Sclerosis in 2024: Enrique Alvarez, MD, PhD

As the landscape of care evolves in multiple sclerosis (MS), clinicians continue their efforts in optimizing therapeutic approaches for patients. Investigating de-escalation of therapies, which involves transitioning patients from high or moderate efficacy disease-modifying therapies to lower efficacy ones to lower risk of adverse effects, has been a topic of interest.